PharmiWeb.com - Global Pharma News & Resources
22-Jul-2019

Molecular Diagnostics Market Revenue Predicted to Go Up by 2018 to 2026

Molecular Diagnostics Market Report offers a complete picture of industry trends and factors along with quantitative data based on historical data and from various sources.

The Global Molecular Diagnostics Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2026.

Request a Sample Copy of this Research Report at https://www.acumenresearchandconsulting.com/request-sample/893

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Molecular Diagnostics Market.

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Molecular Diagnostics Market?
  • What is the market drivers, restrains, opportunities governing the global Molecular Diagnostics Market?
  • Which is the largest and the fastest growing segments in the global Molecular Diagnostics Market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

Market Players:

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market. The Molecular Diagnostics Market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues.

The molecular diagnostics market comprises of some of the major players such as

  • Abbott Molecular Cepheid
  • BioMerieuxrsquo;s
  • Roche diagnostics
  • Danaher Corporation
  • Siemens Healthcare
  • Qiagen Gaithersburg
  • Johnson and Johnson
  • Agilent (Dako)
  • GenMark diagnostics
  • Analytik Jena and Alere Inc.

For instance, in November 2017, Hummingbird Diagnostics GmbH and Saarland University collaborated in early disease detection based on molecular markers.

The Major Market Segments of GlobalMolecular Diagnostics Marketare as below:

Market Segmentation

Market By Product

  • Instruments
  • Reagents
  • Software amp; Services

Market By Technology

  • Polymerase Chain Reactions (PCR)
  • Hybridization
  • DNA Sequencing
  • Microarray
  • Others

Market By Application

  • Infectious Diseases
  • Oncology
  • Genetic Testing
  • Blood Screening
  • Others

Market By End-User

  • Hospital
  • Laboratories
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW 1.1. Definition and Scope 1.1.1. Definition of Molecular Diagnostics 1.1.2. Market Segmentation 1.1.3. List of Abbreviations 1.2. Summary 1.2.1. Market Snapshot 1.2.2. Molecular Diagnostics Market By Product 1.2.2.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By Product (2015-2026) 1.2.2.2. Global Molecular Diagnostics Market Revenue Share By Product in 2017 1.2.2.3. Instruments 1.2.2.4. Reagents 1.2.2.5. Software amp; Services 1.2.2.6. Others 1.2.3. Molecular Diagnostics Market By Technology 1.2.3.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By Technology (2015-2026) 1.2.3.2. Global Molecular Diagnostics Market Revenue Share By Technology in 2017 1.2.3.3. Polymerase Chain Reactions (PCR) 1.2.3.4. Hybridization 1.2.3.5. DNA Sequencing 1.2.3.6. Microarray 1.2.3.7. Others 1.2.4. Molecular Diagnostics Market By Application 1.2.4.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By Application (2015-2026) 1.2.4.2. Global Molecular Diagnostics Market Revenue Share By Application in 2017 1.2.4.3. Infectious Diseases 1.2.4.4. Oncology 1.2.4.5. Genetic Testing 1.2.4.6. Blood Screening 1.2.4.7. Others 1.2.5. Molecular Diagnostics Market By End Users 1.2.5.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison By End Users (2015-2026) 1.2.5.2. Global Molecular Diagnostics Market Revenue Share By End Users in 2017 1.2.5.3. Hospital 1.2.5.4. Laboratories 1.2.5.5. Others 1.2.6. Molecular Diagnostics Market by Geography 1.2.6.1. Global Molecular Diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026) 1.2.6.2. North America Molecular Diagnostics Market Revenue and Growth Rate (2015-2026) 1.2.6.3. Europe Molecular Diagnostics Market Revenue and Growth Rate (2015-2026) 1.2.6.4. Asia-Pacific Molecular Diagnostics Market Revenue and Growth Rate (2015-2026) 1.2.6.5. Latin America Molecular Diagnostics Market Revenue and Growth Rate (2015-2026) 1.2.6.6. Middle East and Africa (MEA) Molecular Diagnostics Market Revenue and Growth Rate (2015-2026) CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS 2.1. Market Drivers 2.2. Restraints and Challenges 2.3. Growth Opportunities 2.4. Porterrsquo;s Five Forces Analysis 2.4.1. Bargaining Power of Suppliers 2.4.2. Bargaining Power of Buyers 2.4.3. Threat of Substitute 2.4.4. Threat of New Entrants 2.4.5. Degree of Competition 2.5. Value Chain Analysis 2.6. Cost Structure Analysis 2.6.1. Raw Material and Suppliers 2.6.2. Manufacturing Process Analysis 2.7. Regulatory Compliance 2.8. Competitive Landscape, 2017 2.8.1. Player Positioning Analysis 2.8.2. Key Strategies Adopted By Leading Players CHAPTER 3. MANUFACTURING PLANTS ANALYSIS 3.1. Capacity and Commercial Production Date of Global Molecular Diagnostics Major Manufacturers in 2017 3.2. Manufacturing Plants Distribution of Global Molecular Diagnostics Major Manufacturers in 2017 3.3. Ramp;D Status and Technology Source of Global Molecular Diagnostics Major Manufacturers in 2017 3.4. Raw Materials Sources Analysis of Global Molecular Diagnostics Major Manufacturers in 2017 CHAPTER 4. Molecular Diagnostics MARKET BY PRODUCT 4.1. Global Molecular Diagnostics Revenue By Product 4.2. Instruments 4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 4.3. Reagents 4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 4.4. Software amp; Services 4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 4.5. Others 4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) CHAPTER 5. Molecular Diagnostics MARKET By Technology 5.1. Global Molecular Diagnostics Revenue By Technology 5.2. Polymerase Chain Reactions (PCR) 5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 5.3. Hybridization 5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 5.4. DNA Sequencing 5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 5.5. Microarray 5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 5.6. Others 5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) CHAPTER 6. Molecular Diagnostics MARKET By Application 6.1. Global Molecular Diagnostics Revenue By Application 6.2. Infectious Diseases 6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 6.3. Oncology 6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 6.4. Genetic Testing 6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 6.5. Blood Screening 6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 6.6. Others 6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) CHAPTER 7. Molecular Diagnostics MARKET By End Users 7.1. Global Molecular Diagnostics Revenue By End Users 7.2. Hospital 7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 7.3. Laboratories 7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) 7.4. Others 7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million) 7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million) CHAPTER 8. NORTH AMERICA Molecular Diagnostics MARKET BY COUNTRY 8.1. North America Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 8.2. North America Molecular Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 8.3. U.S. 8.3.1. U.S. Molecular Diagnostics Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 8.4. Canada 8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 8.5. Mexico 8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) CHAPTER 9. EUROPE Molecular Diagnostics MARKET BY COUNTRY 9.1. Europe Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 9.2. Europe Molecular Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 9.3. UK 9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 9.4. Germany 9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 9.5. France 9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 9.6. Spain 9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 9.7. Rest of Europe 9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) CHAPTER 10. ASIA-PACIFIC Molecular Diagnostics MARKET BY COUNTRY 10.1. Asia-Pacific Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 10.2. Asia-Pacific Molecular Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 10.3. China 10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 10.4. Japan 10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 10.5. India 10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 10.6. Australia 10.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 10.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 10.7. South Korea 10.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 10.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 10.8. Rest of Asia-Pacific 10.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 10.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) CHAPTER 11. LATIN AMERICA Molecular Diagnostics MARKET BY COUNTRY 11.1. Latin America Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 11.2. Latin America Molecular Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 11.3. Brazil 11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 11.4. Argentina 11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 11.5. Rest of Latin America 11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) CHAPTER 12. MIDDLE EAST Molecular Diagnostics MARKET BY COUNTRY 12.1. Middle East Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 12.2. Middle East Molecular Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 12.3. Saudi Arabia 12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 12.4. UAE 12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 12.5. Rest of Middle East 12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) CHAPTER 13. AFRICA Molecular Diagnostics MARKET BY COUNTRY 13.1. Africa Molecular Diagnostics Market Revenue and Growth Rate, 2015 - 2026 ($Million) 13.2. Africa Molecular Diagnostics Market Revenue Share Comparison, 2015 amp; 2026 (%) 13.3. South Africa 13.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 13.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 13.4. Egypt 13.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 13.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 13.5. Rest of Africa 13.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million) 13.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) CHAPTER 14. COMPANY PROFILE 14.1. Abbott Molecular Cepheid 14.1.1. Company Snapshot 14.1.2. Overview 14.1.3. Financial Overview 14.1.4. Product Portfolio 14.1.5. Key Developments 14.1.6. Strategies 14.2. BioMerieuxrsquo;s 14.2.1. Company Snapshot 14.2.2. Overview 14.2.3. Financial Overview 14.2.4. Product Portfolio 14.2.5. Key Developments 14.2.6. Strategies 14.3. Roche diagnostics 14.3.1. Company Snapshot 14.3.2. Overview 14.3.3. Financial Overview 14.3.4. Product Portfolio 14.3.5. Key Developments 14.3.6. Strategies 14.4. Danaher Corporation 14.4.1. Company Snapshot 14.4.2. Overview 14.4.3. Financial Overview 14.4.4. Product Portfolio 14.4.5. Key Developments 14.4.6. Strategies 14.5. Siemens Healthcare 14.5.1. Company Snapshot 14.5.2. Overview 14.5.3. Financial Overview 14.5.4. Product Portfolio 14.5.5. Key Developments 14.5.6. Strategies 14.6. Qiagen Gaithersburg 14.6.1. Company Snapshot 14.6.2. Overview 14.6.3. Financial Overview 14.6.4. Product Portfolio 14.6.5. Key Developments 14.6.6. Strategies 14.7. Johnson and Johnson 14.7.1. Company Snapshot 14.7.2. Overview 14.7.3. Financial Overview 14.7.4. Product Portfolio 14.7.5. Key Developments 14.7.6. Strategies 14.8. Agilent (Dako) 14.8.1. Company Snapshot 14.8.2. Overview 14.8.3. Financial Overview 14.8.4. Product Portfolio 14.8.5. Key Developments 14.8.6. Strategies 14.9. GenMark diagnostics 14.9.1. Company Snapshot 14.9.2. Overview 14.9.3. Financial Overview 14.9.4. Product Portfolio 14.9.5. Key Developments 14.9.6. Strategies 14.10. Analytik Jena and Alere Inc. 14.10.1. Company Snapshot 14.10.2. Overview 14.10.3. Financial Overview 14.10.4. Product Portfolio 14.10.5. Key Developments 14.10.6. Strategies 14.11. Others 14.11.1. Company Snapshot 14.11.2. Overview 14.11.3. Financial Overview 14.11.4. Product Portfolio 14.11.5. Key Developments 14.11.6. Strategies CHAPTER 15. RESEARCH APPROACH 15.1. Research Methodology 15.1.1. Initial Data Search 15.1.2. Secondary Research 15.1.3. Primary Research 15.2. Assumptions and Scope

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/893

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 22-Jul-2019